2000
DOI: 10.1067/mai.2000.105121
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of adhesion of human neutrophils and eosinophils to P-selectin by the sialyl Lewis x antagonist TBC1269: Preferential activity against neutrophil adhesion in vitro

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

3
31
0
1

Year Published

2001
2001
2019
2019

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 55 publications
(35 citation statements)
references
References 26 publications
3
31
0
1
Order By: Relevance
“…The damage caused by hemorrhagic shock was diminished after pretreatment with BIMO (21). Furthermore, BIMO blockade of selectin/PSGL-1 interaction inhibited the PSGL-1-induced expression of adhesion molecules (19). The involvement of selectins in the pathogenesis of renal I/R injury was confirmed by results obtained with another selectin inhibitor, glycyrrhizin (22).…”
supporting
confidence: 67%
See 1 more Smart Citation
“…The damage caused by hemorrhagic shock was diminished after pretreatment with BIMO (21). Furthermore, BIMO blockade of selectin/PSGL-1 interaction inhibited the PSGL-1-induced expression of adhesion molecules (19). The involvement of selectins in the pathogenesis of renal I/R injury was confirmed by results obtained with another selectin inhibitor, glycyrrhizin (22).…”
supporting
confidence: 67%
“…In vitro studies examined the competitive inhibitory effects of BIMO on the binding of beads coated with human E-, P-, or L-selectin/IgG fusion protein to HL60 cells expressing natural sLe x (19). Although the inactive control was ineffective, a 50% inhibitory effect (IC 50 ) was achieved by BIMO at 500 M for E-selectin, 70 M for P-selectin, and 560 M for L-selectin.…”
mentioning
confidence: 99%
“…TBC1269 is a nonoligosaccharide sLe x antagonist and has been shown to block binding to all selectins (39,40). In general, eosinophils have been shown in other studies, as well as the current, to require much more TBC1269 to produce an inhibitory effect compared with the neutrophils (40). In this model of intestinal migration of eosinophils, TBC1269 compound displays potent inhibitory effect, resulting in almost complete abolishment of the migration process.…”
Section: Discussionmentioning
confidence: 95%
“…sLe x binds to the three known selectins; therefore, compounds that inhibit sLe x act as a selectin antagonist. TBC1269 is a nonoligosaccharide sLe x antagonist and has been shown to block binding to all selectins (39,40). In general, eosinophils have been shown in other studies, as well as the current, to require much more TBC1269 to produce an inhibitory effect compared with the neutrophils (40).…”
Section: Discussionmentioning
confidence: 99%
“…In an ovine model of asthma, TBC1269 reduced disease severity. 1 TBC1269 reduces neutrophil infiltration in vitro, 12 and we have shown previously that TBC1269 significantly reduced neutrophil infiltration and vascular leakage of protein, and tended to decrease membrane damage, in calves inoculated with M. haemolytica. 9,28 Characteristic of M. haemolytica pneumonia are the dense infiltrates of neutrophils in the airways and alveoli.…”
mentioning
confidence: 99%